Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic HCT in HIV-Infected Patients with Hematological Malignancies
NCT01410344Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Sep 2011
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Medical College of Wisconsin. Started Sep 2011; status: completed.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndromes (MDS)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01410344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01410344.